CDH1 and breast adenocarcinoma: Osta et al. [43] have reported that similar adeno-carcinomatous tumor cells (i.e., breast adenocarcinoma cells) may show a decreased malignant and metastatic potential following siRNA-mediated EpCAM silencing, as well as a reversal of E-cadherin derangements seen in EpCAM positive cells.